Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder

BJU International

Volumn 99, Issue 2, 2007, Pages 281-285

  Dalbagni, Guido ^a   Parekh, Dipen J ^a   Ben Porat, Leah ^a   Potenzoni, Michele ^a   Herr, Harry W ^a   Reuter, Victor E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bladder cancer; Markers; p53; Survival; T1

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P53; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GROWTH; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CARCINOMA IN SITU; COHORT ANALYSIS; CONTROLLED STUDY; CYSTECTOMY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SCORING SYSTEM; TISSUE TYPING; TRANSITIONAL CELL CARCINOMA; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; CYSTECTOMY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 33846262187     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06624.x     Document Type: Article

References (15)

1. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Algaba F, Vicente-Rodriguez J. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol 2000; 164: 680-4
2. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodriguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000; 163: 73-8
3. Quek ML, Stein JP, Nichols PW et al. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J Urol 2005; 174: 103-6
4. Goddard JC, Sutton CD, Furness PN, O'Byrne KJ, Kockelbergh RC. Microvessel density at presentation predicts subsequent muscle invasion in superficial bladder cancer. Clin Cancer Res 2003; 9: 2583-6
5. Malats N, Bustos A, Nascimento CM et al. P53 as a prognostic marker for bladder cancer: a meta-analysis and review. Lancet Oncol 2005; 6: 678-86
6. Rabbani F, Cordon-Cardo C. Mutation of cell cycle regulators and their impact on superficial bladder cancer. Urol Clin North Am 2000; 27: 83-102
7. Sarkis AS, Dalbagni G, Cordon-Cardo C et al. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Natl Cancer Inst 1993; 85:53-9
8. Reuter VE, Epstein JI, Amin MB, Mostofi FK. The 'WHO/ISUP Consensus Classification of Urothelial (Transitional Cell) Neoplasms': continued discussion. Hum Pathol 1999; 30: 879-80
9. Cordon-Cardo C, Finstad CL, Bander NH, Melamed MR. Immunoanatomic distribution of cytostructural and tissue-associated antigens in the human urinary tract. Am J Pathol 1987; 126: 269-84
10. Banks L, Matlashewski G, Crawford L. Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 1986; 159: 529-34
11. Rivas CI, Wisniewski D, Strife A et al. Constitutive expression of p53 protein in enriched normal human marrow blast cell populations. Blood 1992; 79: 1982-6
12. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 1988; 8: 531-9
13. Queipo Zaragoza JA, Ruiz Cerda JL, Palmero Marti L, Rubio Martinez LA, Vera Sempere F, Jimenez Cruz JF. [Prognostic value for progression of the regulating proteins of the cellular cycle in PT1G3 bladder tumours]. Actas Urol Esp 2005; 29: 261-8
14. Mitra AP, Datar RH, Cote RJ. Molecular staging of bladder cancer. BJU Int 2005; 96: 7-12
15. Lorenzo Romero JG, Salinas Sanchez AS, Gimenez Bachs JM et al. p53 Gene mutations in superficial bladder cancer. Urol Int 2004; 73: 212-8